Comments
Loading...

TG Therapeutics

TGTXNASDAQ
Logo brought to you by Benzinga Data
$31.70
-1.66-4.98%
At close: -
$31.56
-0.14-0.44%
After Hours: Jan 31, 7:45 PM EDT

TG Therapeutics (NASDAQ:TGTX) Stock Quotes, Forecast and News Summary

TG Therapeutics Stock (NASDAQ: TGTX) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
1
Aug 24
1
Sep 24
1
Oct 24
2
1
Nov 24
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$33.33
Close$31.70
Volume / Avg.2.03M / 2.99M
Day Range$31.61 - $33.74
52 Wk Range12.84 - 36.84
Market Cap$4.91B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
52
Short Interest-
Days to Cover8.54

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
TGTX

FAQ

Q

How do I buy TG Therapeutics (TGTX) stock?

A

You can purchase shares of TG Therapeutics (NASDAQ:TGTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are TG Therapeutics (TGTX) competitors?

A

There are no as such competitors for TG Therapeutics.

Q

What is the forecast, or price target, for TG Therapeutics (TGTX) stock?

A

TG Therapeutics has a consensus price target of $30.40.

Q

What is the current price for TG Therapeutics (TGTX)?

A

The stock price for TG Therapeutics (NASDAQ: TGTX) is $31.56 last updated January 31, 2025 at 7:45 PM EST.

Q

Does TG Therapeutics (TGTX) pay a dividend?

A

There are no upcoming dividends for TG Therapeutics.

Q

When is TG Therapeutics (NASDAQ:TGTX) reporting earnings?

A

TG Therapeutics’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Q

Is TG Therapeutics (TGTX) going to split?

A

There is no upcoming split for TG Therapeutics.

Q

What sector and industry does TG Therapeutics (TGTX) operate in?

A

TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.